{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:11:57Z","timestamp":1790331117414,"version":"4.1.0"},"reference-count":43,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.16.04254","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:57:17Z","timestamp":1790330237000},"source":"Crossref","is-referenced-by-count":0,"title":["B3GALT5 regulates renal A\/B antigen levels: a determinant of prognosis and rejection in ABO-incompatible kidney transplantation"],"prefix":"10.7189","volume":"16","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Organ Transplantation Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifu","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Organ Transplantation Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Organ Transplantation Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Organ Transplantation Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianding","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China"},{"name":"Organ Transplantation Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4223","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"key-10.7189\/jogh.16.04254-202609241356-R1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/tri.12616","article-title":"ABO desensitization affects cellular immunity and infection control after renal transplantation.","volume":"28","author":"Schachtner","year":"2015","journal-title":"Transpl Int"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ndt\/gfv388","article-title":"One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.","volume":"31","author":"Zschiedrich","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.transproceed.2013.09.036","article-title":"Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.","volume":"46","author":"Hatakeyama","year":"2014","journal-title":"Transplant Proc"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1053\/j.ajkd.2020.03.029","article-title":"Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.","volume":"76","author":"Massie","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1744-313X.2012.01101.x","article-title":"ABO-incompatible organ transplantation.","volume":"39","author":"Subramanian","year":"2012","journal-title":"Int J Immunogenet"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1097\/TP.0b013e3181726849","article-title":"ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.","volume":"85","author":"Genberg","year":"2008","journal-title":"Transplantation"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1600-6143.2004.00464.x","article-title":"Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan.","volume":"4","author":"Takahashi","year":"2004","journal-title":"Am J Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R8","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/TP.0b013e31819f2024","article-title":"ABO incompatible renal transplantation: a paradigm ready for broad implementation.","volume":"87","author":"Montgomery","year":"2009","journal-title":"Transplantation"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R9","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(18)32091-9","article-title":"Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis.","volume":"393","author":"Scurt","year":"2019","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.krcp.2015.08.005","article-title":"Current progress in ABO-incompatible kidney transplantation.","volume":"34","author":"Koo","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R11","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1111\/ajt.12920","article-title":"ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone.","volume":"14","author":"Masterson","year":"2014","journal-title":"Am J Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/iju.14109","article-title":"Latest insights on ABO-incompatible living-donor renal transplantation.","volume":"27","author":"Uchida","year":"2020","journal-title":"Int J Urol"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R13","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1034\/j.1600-6143.2003.00179.x","article-title":"Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury.","volume":"3","author":"Park","year":"2003","journal-title":"Am J Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/00007890-199409000-00015","article-title":"Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants.","volume":"58","author":"Fryer","year":"1994","journal-title":"Transplantation"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.tp.0000231697.15817.51","article-title":"Blood group A and B antigen expression in human kidneys correlated to A1\/A2\/B, Lewis, and secretor status.","volume":"82","author":"Breimer","year":"2006","journal-title":"Transplantation"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.carpath.2012.10.007","article-title":"Blood Group A antigen expression on cardiac endothelium is highly individualized: possible implications for transplantation.","volume":"22","author":"Gehrie","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R17","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1111\/ajt.13328","article-title":"Chemical Basis for Qualitative and Quantitative Differences Between ABO Blood Groups and Subgroups: Implications for Organ Transplantation.","volume":"15","author":"Jeyakanthan","year":"2015","journal-title":"Am J Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R18","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/ajt.13625","article-title":"ABH-Glycan Microarray Characterizes ABO Subtype Antibodies: Fine Specificity of Immune Tolerance After ABO-Incompatible Transplantation.","volume":"16","author":"Jeyakanthan","year":"2016","journal-title":"Am J Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R19","doi-asserted-by":"publisher","first-page":"e920224","DOI":"10.12659\/AOT.920224","article-title":"Individualized Preconditioning for ABO-Incompatible Living-Donor Kidney Transplantation: An Initial Report of 48 Cases from China.","volume":"25","author":"Wang","year":"2020","journal-title":"Ann Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ahg.12441","article-title":"Effect of high variation in transcript expression on identifying differentially expressed genes in RNA-seq analysis.","volume":"85","author":"Cui","year":"2021","journal-title":"Ann Hum Genet"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10157-007-0461-z","article-title":"Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation.","volume":"11","author":"Takahashi","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/ajt.15553","article-title":"Peripheral blood transcriptome analysis and development of classification model for diagnosing antibody-mediated rejection vs accommodation in ABO-incompatible kidney transplant.","volume":"20","author":"Jeon","year":"2020","journal-title":"Am J Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R24","doi-asserted-by":"publisher","first-page":"12499","DOI":"10.1074\/jbc.274.18.12499","article-title":"Cloning, expression, and characterization of a novel UDP-galactose:beta-N-acetylglucosamine beta1,3-galactosyltransferase (beta3Gal-T5) responsible for synthesis of type 1 chain in colorectal and pancreatic epithelia and tumor cells derived therefrom.","volume":"274","author":"Isshiki","year":"1999","journal-title":"J Biol Chem"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R25","doi-asserted-by":"publisher","first-page":"e12418","DOI":"10.1111\/xen.12418","article-title":"Accommodation in ABO-incompatible organ transplants.","volume":"25","author":"Garcia de Mattos Barbosa","year":"2018","journal-title":"Xenotransplantation"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12865-021-00456-2","article-title":"Highly individual- and tissue-specific expression of glycoprotein group A and B blood antigens in the human kidney and liver.","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Immunol"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.transci.2012.08.002","article-title":"Serological characteristic and molecular basis of A2 subgroup in the Chinese population.","volume":"48","author":"Ying","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R28","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1111\/ajt.16712","article-title":"Characterization of ABH-subtype donor-specific antibodies in ABO-A-incompatible kidney transplantation.","volume":"21","author":"Bentall","year":"2021","journal-title":"Am J Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R29","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00018-022-04601-x","article-title":"B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR\/p70s6k-mediated glycolysis.","volume":"80","author":"Zhang","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s13258-021-01072-5","article-title":"B3GNT3 acts as a carcinogenic factor in endometrial cancer via facilitating cell growth, invasion and migration through regulating RhoA\/RAC1 pathway-associated markers.","volume":"43","author":"Wang","year":"2021","journal-title":"Genes Genomics"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R32","doi-asserted-by":"publisher","first-page":"103658","DOI":"10.1016\/j.jri.2022.103658","article-title":"Upregulation of B3GNT3 is associated with immune infiltration and activation of NF-\u03baB pathway in gynecologic cancers.","volume":"152","author":"Xu","year":"2022","journal-title":"J Reprod Immunol"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/glycob\/cwg048","article-title":"Alpha1,3-fucosyltransferase IX (Fut9) determines Lewis X expression in brain.","volume":"13","author":"Nishihara","year":"2003","journal-title":"Glycobiology"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/ctr.12527","article-title":"Transplantation of ABO A2 kidneys into O recipients: do IgM anti-A1 titers matter?","volume":"29","author":"Tierney","year":"2015","journal-title":"Clin Transplant"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R36","first-page":"173","article-title":"Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.","volume":"32","author":"Babu","year":"2016","journal-title":"Clin Transpl"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00595-021-02293-7","article-title":"Circulating anti-human leukocyte antigen IgM antibodies as a potential early predictor of allograft rejection and a negative clinical outcome after lung transplantation.","volume":"52","author":"Miyahara","year":"2022","journal-title":"Surg Today"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group.","volume":"30","author":"Poupon","year":"1999","journal-title":"J Hepatol"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1352458510388543","article-title":"Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.","volume":"17","author":"Stauch","year":"2011","journal-title":"Mult Scler"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-319-18603-0_8","article-title":"Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues.","volume":"865","author":"Platt","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R41","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1073\/pnas.80.12.3816","article-title":"Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics.","volume":"80","author":"Koski","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4049\/jimmunol.138.1.246","article-title":"Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis.","volume":"138","author":"Morgan","year":"1987","journal-title":"J Immunol"},{"key":"key-10.7189\/jogh.16.04254-202609241356-R43","first-page":"44","article-title":"Cytotoxic action and other metabolic consequences of terminal complement proteins.","volume":"40","author":"Shin","year":"1988","journal-title":"Prog Allergy"}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:57:19Z","timestamp":1790330239000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7189\/jogh.16.04254","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"04254"}}